Back

Therapeutic effect of selective serotonin reuptake inhibitors to gain-of-function KCND3 variant identified in a patient with early repolarization and refractory epilepsy.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of arrhythmias Ion Channel Disorders ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Tserenlkham Byambajav

National Cerebral & Cardiovascular Center, Suita (Japan)

7 More presentations in this session

Presentation thumbnail
Piezo1-Mediated TGF-beta2 autocrine loop promotes atrial fibrosis and fibrillation under pressure overload
Doctor H. Wu (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
Genetic factors in risk stratification of concealed long QT patients with no history of beta-blocker use
Doctor A. Savelev (Lund, SE)
Abstract Slides Video
Presentation thumbnail
New phenotypic association for SMAD6 gene: its role in the development of cardiac conduction disorders and pulmonary arterial hypertension/hereditary haemorrhagic telangiectasia.
Doctor A. Amor Salamanca (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Elucidation of the pathogenesis in long QT syndrome caused by a CALM2 variant, p.D134H, using knock-in mouse model
Doctor S. Ohno (Suita, JP)
Abstract Slides Video
Presentation thumbnail
New genetic risk factor for serious cardiac events in Andersen-Tawil Syndrome - p.Arg71Gln variant in BAG3.
Ms M. Krych (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of arrhythmias

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Mexiletine shortened QTc interval in an age-dependent manner but suppressed ventricular arrhythmias at all age in children with long QT syndrome type 8
thumbnail
Congress Presentation
In vivo KCNQ1-suppression-replacement gene therapy in transgenic LQT1 rabbits restores a physiological QT interval at baseline and under catecholamine infusion
thumbnail
Congress Presentation
Investigation of a novel SLC4A3 variant causing short QT Syndrome: functional and pharmacological evaluation in a knock-in zebrafish model

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources